Better image post-processing enables simplified bowel preparation with no effect on virtual colonoscopy image quality, an Italian team of radiologists found in a preliminary study published in La Radiologia Medica.
Better image post-processing enables simplified bowel preparation with no effect on virtual colonoscopy image quality, an Italian team of radiologists found in a preliminary study published in La Radiologia Medica.
The authors assessed the quality, diagnostic accuracy and patient acceptability of CT colonography performed using a simplified bowel preparation and software for post-processing digital elimination of stool and fluid data from images. They compared the results with the images obtained with conventional preparation.
Two groups of 40 asymptomatic patients aged between 48 and 72 years underwent CT colonography. In the first group, the CT scan was performed with conventional bowel preparation involving a full cathartic dose and oral contrast medium to tag any residue in the three days preceding the study. In the second group, the team did CT colonography after a reduced bowel preparation, with the oral contrast medium for residue tagging being administered only on the day of the investigation. Examination quality, diagnostic performance and patient acceptability (rated with a self-completed questionnaire) were assessed in the two groups of patients.
The team found no significant difference in examination quality (180 vs. 165 segments were free from stools and fluid) or overall diagnostic accuracy (16/17 polyps detected in the first group and 12/13 in the second).The patients appreciated the easier preparation, too, according to their questionnaires.
“The use of software for post-processing digital elimination of residue from images in conjunction with reduced bowel preparation does not reduce examination quality or diagnostic performance when compared with the conventional CT colonography technique and is more acceptable to and better tolerated by the patient,” the authors concluded.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.